{"uri":"targeting-hepatic-heparin-binding-egf-like-growth-ix2cfqe","version_id":"0","protocol_name":"Targeting hepatic heparin-binding EGF-like growth factor (HB-EGF) using HB-EGF-specific antisense oligonucleotide (ASO)","protocol_name_html":"Targeting hepatic heparin-binding EGF-like growth factor (HB-EGF) using HB-EGF-specific antisense oligonucleotide (ASO)","is_prepublished":"0","can_edit":"0","parent_id":null,"api_version":"1","is_new_mode":"0","last_modified":"1520661601","type_id":"1","link":null,"fork_id":"","public_fork_note":null,"number_of_steps":"0","has_versions":"0","first_published_date":"1506678130","publish_date":"2017-09-29 09:42:10","documents":null,"have_protocol_in_step":"0","is_protocol_in_step":"0","vendor_name":"Contributed by users","vendor_link":"https:\/\/www.protocols.io","vendor_logo":"\/img\/vendors\/1.png","mod_mins":"-45","mod_secs":"1","description":null,"is_bookmarked":"0","can_reassign":"0","before_start":null,"has_guidelines":"0","materials":[],"warning":null,"version_class":"6874","public":"1","is_owner":"0","is_original_owner":"0","created_on":"1500045721","protocol_affiliation":"","affiliation":null,"doi":null,"doi_status":"0","changed_fork_steps":null,"profile_url":null,"protocol_img":"https:\/\/www.protocols.io\/img\/default_protocol.png","profile_image":null,"full_name":null,"created_by":null,"private_link":null,"original_img":"1","username":null,"is_retracted":"0","retraction_reason":null,"plos_id":null,"manuscript_citation":null,"journal_name":null,"is_donations_disabled":"0","is_donations_disabled_by_user":"9","item_record_id":247936,"fork_info":[],"compare_forks":[],"protocols":[],"groups":[],"number_of_shared_runs":[],"ownership_history":[],"keywords":"","transfer_to_user":[],"sub_transfer":false,"is_transfer_pending":false,"number_of_bookmarks":"0","collections":[],"tags":[],"archived":0,"sub_authors":[],"sub_protocols_number":0,"can_edit_shared":0,"shared_runs":[],"is_shared_run":0,"is_shared":1,"banner":null,"contact_badges":[],"number_of_comments":0,"is_locked":0,"is_locked_by":false,"authors":"","authors_list":[],"user":{"profile_image":null,"username":null,"full_name":null,"created_by":null},"access":{"can_view":null,"can_remove":null,"can_add":null,"can_edit":0,"can_publish":0,"can_get_doi":null,"can_share":null,"can_move":null,"can_transfer":null,"can_download":null,"is_locked":null},"is_contact_suspended":0,"guidelines":null,"status_id":"1","is_research":"1","status_info":null,"steps":[{"id":"579399","is_changed":"0","original_id":"0","is_skipped":"0","is_checked":"0","guid":"78386B17FF274BD687112A140F2860EA","previous_guid":null,"previous_id":null,"last_modified":"1500048133","components":[{"component_id":"961635","previous_id":0,"original_id":"0","guid":"9FDB315DAC62492FA10518BA45E3DAB6","previous_guid":null,"component_type_id":"1","data_id":null,"data":"<ul>\n<li>Control ASO (549144: 5\u2032- <u>GGC<\/u>CAATACGCCG<u>TCA<\/u> -3\u2032) and HB-EGF ASO (597622: 5 \u2032-<u>TAC<\/u>ATTATAGTCT<u>TGG<\/u> -3\u2032) were synthesized and purified by Ionis<\/li>\n<li>Poloxamer-407, a lipoprotein lipase inhibitor, was purchased from Sigma-Aldrich (Cat No. 16758)<\/li>\n<li>Recombinant HB-EGF (human) was purchased from R&amp;D systems (Cat No. 295-HE-CF).<\/li>\n<\/ul>","order_id":"0","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<ul>\n<li>Control ASO (549144: 5\u2032- <u>GGC<\/u>CAATACGCCG<u>TCA<\/u> -3\u2032) and HB-EGF ASO (597622: 5 \u2032-<u>TAC<\/u>ATTATAGTCT<u>TGG<\/u> -3\u2032) were synthesized and purified by Ionis<\/li>\n<li>Poloxamer-407, a lipoprotein lipase inhibitor, was purchased from Sigma-Aldrich (Cat No. 16758)<\/li>\n<li>Recombinant HB-EGF (human) was purchased from R&amp;D systems (Cat No. 295-HE-CF).<\/li>\n<\/ul>"},"is_project":0},{"component_id":"961636","previous_id":"961635","original_id":"0","guid":"011EC58E1B524F399743EBB264D2EAF5","previous_guid":"9FDB315DAC62492FA10518BA45E3DAB6","component_type_id":"6","data_id":null,"data":"Materials","order_id":"1","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":"Materials"},"is_project":0}]},{"id":"579401","is_changed":"0","original_id":"0","is_skipped":"0","is_checked":"0","guid":"A73A3EB971FC4BB5B86E2F4A11FB25C1","previous_guid":"78386B17FF274BD687112A140F2860EA","previous_id":"579399","last_modified":"1500048252","components":[{"component_id":"961639","previous_id":0,"original_id":"0","guid":"5D52900D067841EC9FB1064E4F8497E8","previous_guid":null,"component_type_id":"1","data_id":null,"data":"<ul>\n<li>Male LDLR deficient mice (Jackson Laboratory, 8-10 weeks of ages; stock # 002207) were used for study<\/li>\n<\/ul>\n<ol>\n<li>The mice were treated with either control or HB-EGF ASOs at a dose of 40 mg\/kg\/wk for 10 weeks<\/li>\n<li>To induce hyperlipidemia in the mice, HFD (Harlan, Cat No TD-88137) was fed ad libitum during the last 5 weeks<\/li>\n<li>To expedite lesion and aneurysm development, AngII infusion (1,000 ng\/kg\/min, Bachem, Torrance, CA), ) via osmotic minipump implanted during the last 4 weeks of the study<\/li>\n<li>Topically analgesic application was performed immediately after and 3-4 hours post-surgery to ameliorate pain at incision site<\/li>\n<\/ol>","order_id":"0","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<ul>\n<li>Male LDLR deficient mice (Jackson Laboratory, 8-10 weeks of ages; stock # 002207) were used for study<\/li>\n<\/ul>\n<ol>\n<li>The mice were treated with either control or HB-EGF ASOs at a dose of 40 mg\/kg\/wk for 10 weeks<\/li>\n<li>To induce hyperlipidemia in the mice, HFD (Harlan, Cat No TD-88137) was fed ad libitum during the last 5 weeks<\/li>\n<li>To expedite lesion and aneurysm development, AngII infusion (1,000 ng\/kg\/min, Bachem, Torrance, CA), ) via osmotic minipump implanted during the last 4 weeks of the study<\/li>\n<li>Topically analgesic application was performed immediately after and 3-4 hours post-surgery to ameliorate pain at incision site<\/li>\n<\/ol>"},"is_project":0},{"component_id":"961640","previous_id":"961639","original_id":"0","guid":"B6F2DDAB3F5B48F8ABE8988C04E7B4B4","previous_guid":"5D52900D067841EC9FB1064E4F8497E8","component_type_id":"6","data_id":null,"data":"Animals","order_id":"1","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":"Animals"},"is_project":0}]},{"id":"579402","is_changed":"0","original_id":"0","is_skipped":"0","is_checked":"0","guid":"C20B70AF6FD6490198B987CC572FC243","previous_guid":"A73A3EB971FC4BB5B86E2F4A11FB25C1","previous_id":"579401","last_modified":"1500048378","components":[{"component_id":"961641","previous_id":0,"original_id":"0","guid":"07D22D0C915A4E2FB8B50474135E4958","previous_guid":null,"component_type_id":"1","data_id":null,"data":"<ul>\n<li>Blood pressure is measured using the Kent blood pressure machine as described in the previous report<\/li>\n<li>This unit is a computerized, non\u2212invasive tail\u2212cuff system for measuring mouse systolic and diastolic blood pressure<\/li>\n<\/ul>\n<ol>\n<li>A platform is warmed to 37 <sup>o<\/sup>C to keep mice warm<\/li>\n<li>Mice are placed in plexi\u2212glass holders<\/li>\n<li>Tails are threaded through an O\u2212ring and VPR\u2212ring<\/li>\n<li>The 10 preliminary and 10 actual measurements are made in 15 minutes<\/li>\n<li>The mice are housed comfortably in holders<\/li>\n<li>We measured blood pressure three consecutive days at the same time<\/li>\n<li>\n<p>Only mice that measured 50% (10<\/p>\nmeasurements) with a SD &lt; 30 mmHg were accepted<\/li>\n<\/ol>","order_id":"0","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<ul>\n<li>Blood pressure is measured using the Kent blood pressure machine as described in the previous report<\/li>\n<li>This unit is a computerized, non\u2212invasive tail\u2212cuff system for measuring mouse systolic and diastolic blood pressure<\/li>\n<\/ul>\n<ol>\n<li>A platform is warmed to 37 <sup>o<\/sup>C to keep mice warm<\/li>\n<li>Mice are placed in plexi\u2212glass holders<\/li>\n<li>Tails are threaded through an O\u2212ring and VPR\u2212ring<\/li>\n<li>The 10 preliminary and 10 actual measurements are made in 15 minutes<\/li>\n<li>The mice are housed comfortably in holders<\/li>\n<li>We measured blood pressure three consecutive days at the same time<\/li>\n<li>\n<p>Only mice that measured 50% (10<\/p>\nmeasurements) with a SD &lt; 30 mmHg were accepted<\/li>\n<\/ol>"},"is_project":0},{"component_id":"961642","previous_id":"961641","original_id":"0","guid":"467CACBFE39540CCB6E21473081714CA","previous_guid":"07D22D0C915A4E2FB8B50474135E4958","component_type_id":"6","data_id":null,"data":"Noninvasive tail cuff method to measure blood pressure","order_id":"1","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":"Noninvasive tail cuff method to measure blood pressure"},"is_project":0}]}]}